DOI: 10.1158/1055-9965.1271.13.8. XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer

XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer

10.1158/1055-9965.1271.13.8

Crossref journal-article

American Association for Cancer Research (AACR)

Cancer Epidemiology, Biomarkers & Prevention (1086)

Abstract

Abstract Background: Individuals with nonmelanoma skin cancer (NMSC) are at increased risk of developing subsequent cancers. Genetic predisposition to reduced DNA repair capacity may be an underlying susceptibility factor explaining the excess risk of malignancies. To test this hypothesis, a cohort study was conducted to examine the association between XPD Lys751Gln polymorphism and risk of a second primary cancer in individuals with NMSC. Methods: A subgroup of 481 individuals with a history of NMSC who participated in the CLUE II community-based cohort was followed for the development of a second primary cancer. Blood specimens donated in 1989 were genotyped for the XPD Lys751Gln polymorphism using the 5′ nuclease assay. Cox proportional regression with delayed entry was used to calculate the incidence rate ratio (IRR) and 95% confidence interval (95% CI) for risk of developing a second primary cancer according to XPD genotype. All statistical tests were two sided. Results: Eighty individuals developed a second primary cancer. The most frequent occurring cancers were of the prostate (18%), lung (15%), and breast (15%). Persons with at least one Gln allele had an increased risk of a second primary cancer compared with the reference Lys/Lys genotype (adjusted IRR 2.22, 95% CI 1.30-3.76). When the reference category was limited to never smokers with the Lys/Lys genotype, the risk of developing a second primary cancer associated with having at least one Gln allele was increased &gt;3-fold in both never smokers (IRR 3.93, 95% CI 1.36-11.36) and ever smokers (IRR 6.14, 95% CI 2.17-17.37). Conclusion: These findings suggest that individuals with NMSC who have the variant XPD Gln allele are at increased risk of developing a second primary cancer.

Bibliography

Brewster, A. M., Alberg, A. J., Strickland, P. T., Hoffman, S. C., & Helzlsouer, K. (2004). XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer. Cancer Epidemiology, Biomarkers & Prevention, 13(8), 1271â1275.

Authors 5

Abenaa M. Brewster (first)
Anthony J. Alberg (additional)
Paul T. Strickland (additional)
Sandy C. Hoffman (additional)
Kathy Helzlsouer (additional)

References 42 Referenced 31

Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. 2002. CA Cancer J Clin 2002;52:23-47. (10.3322/canjclin.52.1.23)
Scotto JFT, Fraumeni JF. Solar radiation. In: Schottenfeld FJ, editor. Cancer epidemiology and prevention. New York: Oxford University Press; 1996. p. 355-72.
de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453-60. (10.1093/carcin/21.3.453)
Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133:1263-70. (10.1001/archderm.133.10.1263)
Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-8. (10.1073/pnas.88.22.10124)
Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995;141:916-22. (10.1093/oxfordjournals.aje.a117358)
Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996;125:815-21. (10.7326/0003-4819-125-10-199611150-00005)
Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 2000;136:647-51. (10.1001/archderm.136.5.647)
Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers & Prev 1998;7:157-61.
Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997;146:734-9. (10.1093/oxfordjournals.aje.a009349)
Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147:722-6. (10.1093/oxfordjournals.aje.a009516)
Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991;25:245-8. (10.1016/0190-9622(91)70189-9)
Milan T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000;87:283-8. (10.1002/1097-0215(20000715)87:2<283::AID-IJC21>3.0.CO;2-I)
Teppo L, Pukkala E, Saxen E. Multiple cancer—an epidemiologic exercise in Finland. J Natl Cancer Inst 1985;75:207-17.
Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 1999;80:511-5. (10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.0.CO;2-P)
Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 2002;12:469-75. (10.1016/S1047-2797(01)00276-9)
Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes & Control 2000;11:891-7. (10.1023/A:1026591016153)
Troyanova P, Danon S, Ivanova T. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 2002;49:81-5.
Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. Association of nonmelanoma skin cancer with second malignancy. Cancer 2004;100:130-8. (10.1002/cncr.11874)
Askling J, Sorensen P, Ekbom A, et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann Intern Med 1999;131:655-9. (10.7326/0003-4819-131-9-199911020-00004)
Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998;280:910-2. (10.1001/jama.280.10.910)
Strickland PT. DNA damage and repair. In: Miller SJ and Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis and management. Blackwell Sci Ltd: Oxford, 1998. p. 110-4.
Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers & Prev 2002;11:1513-30.
Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-8.
Hoeijmakers JH, Egly JM, Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr Opin Genet Dev 1996;6:26-33. (10.1016/S0959-437X(96)90006-4)
Sung P, Bailly V, Weber C, Thompson LH, Prakash L, Prakash S. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature 1993;365:852-5. (10.1038/365852a0)
Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511-4. (10.1093/carcin/5.4.511)
Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000;21:551-5. (10.1093/carcin/21.4.551)
Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001;61:1354-7.
Qiao Y, Spitz MR, Guo Z, et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 2002;509:165-74. (10.1016/S0027-5107(02)00219-1)
Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002;23:295-9. (10.1093/carcin/23.2.295)
Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers & Prev 1999;8:525-32.
Klintschar M, Neuhuber F. Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci 2000;45:669-73. (10.1520/JFS14745J)
Therneau T, Granbsch P. Modeling survival data: extending the Cox model. New York: Springer-Verlag; 2000. (10.1007/978-1-4757-3294-8)
Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7. (10.1002/ijc.1228)
Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002;23:599-603. (10.1093/carcin/23.4.599)
Palli D, Russo A, Masala G, et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer 2001;94:121-7. (10.1002/ijc.1433)
Zhou W, Liu G, Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002;62:1377-81.
Sturgis EM, Zheng R, Li L, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000;21:2219-23. (10.1093/carcin/21.12.2219)
Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002;23:1321-5. (10.1093/carcin/23.8.1321)
Tang D, Cho S, Rundle A, et al. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 2002;75:159-66. (10.1023/A:1019693504183)
Shen H, Spitz MR, Qiao Y, et al. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 2003;107:84-8. (10.1002/ijc.11346)

Dates

Type	When
Created	3 years, 2 months ago (June 10, 2022, 12:20 a.m.)
Deposited	3 years, 2 months ago (June 10, 2022, 12:21 a.m.)
Indexed	1 month ago (July 26, 2025, 5:13 a.m.)
Issued	21 years ago (Aug. 1, 2004)
Published	21 years ago (Aug. 1, 2004)
Published Online	21 years ago (Aug. 6, 2004)
Published Print	21 years ago (Aug. 1, 2004)

Funders 0

None

BibTeX

@article{Brewster_2004, title={XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer}, volume={13}, ISSN={1538-7755}, url={http://dx.doi.org/10.1158/1055-9965.1271.13.8}, DOI={10.1158/1055-9965.1271.13.8}, number={8}, journal={Cancer Epidemiology, Biomarkers & Prevention}, publisher={American Association for Cancer Research (AACR)}, author={Brewster, Abenaa M. and Alberg, Anthony J. and Strickland, Paul T. and Hoffman, Sandy C. and Helzlsouer, Kathy}, year={2004}, month=aug, pages={1271–1275} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        26
      ]
    ],
    "date-time": "2025-07-26T09:13:56Z",
    "timestamp": 1753521236021
  },
  "reference-count": 42,
  "publisher": "American Association for Cancer Research (AACR)",
  "issue": "8",
  "content-domain": {
    "domain": [
      "aacrjournals.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        8,
        1
      ]
    ]
  },
  "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Background: Individuals with nonmelanoma skin cancer (NMSC) are at increased risk of developing subsequent cancers. Genetic predisposition to reduced DNA repair capacity may be an underlying susceptibility factor explaining the excess risk of malignancies. To test this hypothesis, a cohort study was conducted to examine the association between XPD Lys751Gln polymorphism and risk of a second primary cancer in individuals with NMSC. Methods: A subgroup of 481 individuals with a history of NMSC who participated in the CLUE II community-based cohort was followed for the development of a second primary cancer. Blood specimens donated in 1989 were genotyped for the XPD Lys751Gln polymorphism using the 5\u2032 nuclease assay. Cox proportional regression with delayed entry was used to calculate the incidence rate ratio (IRR) and 95% confidence interval (95% CI) for risk of developing a second primary cancer according to XPD genotype. All statistical tests were two sided. Results: Eighty individuals developed a second primary cancer. The most frequent occurring cancers were of the prostate (18%), lung (15%), and breast (15%). Persons with at least one Gln allele had an increased risk of a second primary cancer compared with the reference Lys/Lys genotype (adjusted IRR 2.22, 95% CI 1.30-3.76). When the reference category was limited to never smokers with the Lys/Lys genotype, the risk of developing a second primary cancer associated with having at least one Gln allele was increased &amp;gt;3-fold in both never smokers (IRR 3.93, 95% CI 1.36-11.36) and ever smokers (IRR 6.14, 95% CI 2.17-17.37). Conclusion: These findings suggest that individuals with NMSC who have the variant XPD Gln allele are at increased risk of developing a second primary cancer.</jats:p>",
  "DOI": "10.1158/1055-9965.1271.13.8",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2022,
        6,
        10
      ]
    ],
    "date-time": "2022-06-10T04:20:21Z",
    "timestamp": 1654834821000
  },
  "page": "1271-1275",
  "update-policy": "http://dx.doi.org/10.1158/crossmark_policy",
  "source": "Crossref",
  "is-referenced-by-count": 31,
  "title": "XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer",
  "prefix": "10.1158",
  "volume": "13",
  "author": [
    {
      "given": "Abenaa M.",
      "family": "Brewster",
      "sequence": "first",
      "affiliation": [
        {
          "name": "1Department of Clinical Cancer Prevention, University of Texas M.D. Anderson Cancer Center, Houston, Texas and Departments of"
        }
      ]
    },
    {
      "given": "Anthony J.",
      "family": "Alberg",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "2Epidemiology and"
        }
      ]
    },
    {
      "given": "Paul T.",
      "family": "Strickland",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "3Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"
        }
      ]
    },
    {
      "given": "Sandy C.",
      "family": "Hoffman",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "2Epidemiology and"
        }
      ]
    },
    {
      "given": "Kathy",
      "family": "Helzlsouer",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "2Epidemiology and"
        }
      ]
    }
  ],
  "member": "1086",
  "published-online": {
    "date-parts": [
      [
        2004,
        8,
        6
      ]
    ]
  },
  "reference": [
    {
      "key": "2022060923194762800_BIB1",
      "doi-asserted-by": "crossref",
      "unstructured": "Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. 2002. CA Cancer J Clin\u20082002;52:23-47.",
      "DOI": "10.3322/canjclin.52.1.23"
    },
    {
      "key": "2022060923194762800_BIB2",
      "unstructured": "Scotto JFT, Fraumeni JF. Solar radiation. In: Schottenfeld FJ, editor. Cancer epidemiology and prevention. New York: Oxford University Press; 1996. p. 355-72."
    },
    {
      "key": "2022060923194762800_BIB3",
      "doi-asserted-by": "crossref",
      "unstructured": "de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis\u20082000;21:453-60.",
      "DOI": "10.1093/carcin/21.3.453"
    },
    {
      "key": "2022060923194762800_BIB4",
      "doi-asserted-by": "crossref",
      "unstructured": "Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol\u20081997;133:1263-70.",
      "DOI": "10.1001/archderm.133.10.1263"
    },
    {
      "key": "2022060923194762800_BIB5",
      "doi-asserted-by": "crossref",
      "unstructured": "Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA\u20081991;88:10124-8.",
      "DOI": "10.1073/pnas.88.22.10124"
    },
    {
      "key": "2022060923194762800_BIB6",
      "doi-asserted-by": "crossref",
      "unstructured": "Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol\u20081995;141:916-22.",
      "DOI": "10.1093/oxfordjournals.aje.a117358"
    },
    {
      "key": "2022060923194762800_BIB7",
      "doi-asserted-by": "crossref",
      "unstructured": "Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med\u20081996;125:815-21.",
      "DOI": "10.7326/0003-4819-125-10-199611150-00005"
    },
    {
      "key": "2022060923194762800_BIB8",
      "doi-asserted-by": "crossref",
      "unstructured": "Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol\u20082000;136:647-51.",
      "DOI": "10.1001/archderm.136.5.647"
    },
    {
      "key": "2022060923194762800_BIB9",
      "unstructured": "Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers & Prev\u20081998;7:157-61."
    },
    {
      "key": "2022060923194762800_BIB10",
      "doi-asserted-by": "crossref",
      "unstructured": "Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol\u20081997;146:734-9.",
      "DOI": "10.1093/oxfordjournals.aje.a009349"
    },
    {
      "key": "2022060923194762800_BIB11",
      "doi-asserted-by": "crossref",
      "unstructured": "Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol\u20081998;147:722-6.",
      "DOI": "10.1093/oxfordjournals.aje.a009516"
    },
    {
      "key": "2022060923194762800_BIB12",
      "doi-asserted-by": "crossref",
      "unstructured": "Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol\u20081991;25:245-8.",
      "DOI": "10.1016/0190-9622(91)70189-9"
    },
    {
      "key": "2022060923194762800_BIB13",
      "doi-asserted-by": "crossref",
      "unstructured": "Milan T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer\u20082000;87:283-8.",
      "DOI": "10.1002/1097-0215(20000715)87:2<283::AID-IJC21>3.0.CO;2-I"
    },
    {
      "key": "2022060923194762800_BIB14",
      "unstructured": "Teppo L, Pukkala E, Saxen E. Multiple cancer\u2014an epidemiologic exercise in Finland. J Natl Cancer Inst\u20081985;75:207-17."
    },
    {
      "key": "2022060923194762800_BIB15",
      "doi-asserted-by": "crossref",
      "unstructured": "Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer\u20081999;80:511-5.",
      "DOI": "10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.0.CO;2-P"
    },
    {
      "key": "2022060923194762800_BIB16",
      "doi-asserted-by": "crossref",
      "unstructured": "Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol\u20082002;12:469-75.",
      "DOI": "10.1016/S1047-2797(01)00276-9"
    },
    {
      "key": "2022060923194762800_BIB17",
      "doi-asserted-by": "crossref",
      "unstructured": "Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes & Control\u20082000;11:891-7.",
      "DOI": "10.1023/A:1026591016153"
    },
    {
      "key": "2022060923194762800_BIB18",
      "unstructured": "Troyanova P, Danon S, Ivanova T. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma\u20082002;49:81-5."
    },
    {
      "key": "2022060923194762800_BIB19",
      "doi-asserted-by": "crossref",
      "unstructured": "Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. Association of nonmelanoma skin cancer with second malignancy. Cancer\u20082004;100:130-8.",
      "DOI": "10.1002/cncr.11874"
    },
    {
      "key": "2022060923194762800_BIB20",
      "doi-asserted-by": "crossref",
      "unstructured": "Askling J, Sorensen P, Ekbom A, et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann Intern Med\u20081999;131:655-9.",
      "DOI": "10.7326/0003-4819-131-9-199911020-00004"
    },
    {
      "key": "2022060923194762800_BIB21",
      "doi-asserted-by": "crossref",
      "unstructured": "Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA\u20081998;280:910-2.",
      "DOI": "10.1001/jama.280.10.910"
    },
    {
      "key": "2022060923194762800_BIB22",
      "unstructured": "Strickland PT. DNA damage and repair. In: Miller SJ and Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis and management. Blackwell Sci Ltd: Oxford, 1998. p. 110-4."
    },
    {
      "key": "2022060923194762800_BIB23",
      "unstructured": "Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers & Prev\u20082002;11:1513-30."
    },
    {
      "key": "2022060923194762800_BIB24",
      "unstructured": "Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res\u20081998;58:604-8."
    },
    {
      "key": "2022060923194762800_BIB25",
      "doi-asserted-by": "crossref",
      "unstructured": "Hoeijmakers JH, Egly JM, Vermeulen W. TFIIH: a key component in multiple DNA transactions. Curr Opin Genet Dev\u20081996;6:26-33.",
      "DOI": "10.1016/S0959-437X(96)90006-4"
    },
    {
      "key": "2022060923194762800_BIB26",
      "doi-asserted-by": "crossref",
      "unstructured": "Sung P, Bailly V, Weber C, Thompson LH, Prakash L, Prakash S. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature\u20081993;365:852-5.",
      "DOI": "10.1038/365852a0"
    },
    {
      "key": "2022060923194762800_BIB27",
      "doi-asserted-by": "crossref",
      "unstructured": "Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis\u20081984;5:511-4.",
      "DOI": "10.1093/carcin/5.4.511"
    },
    {
      "key": "2022060923194762800_BIB28",
      "doi-asserted-by": "crossref",
      "unstructured": "Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis\u20082000;21:551-5.",
      "DOI": "10.1093/carcin/21.4.551"
    },
    {
      "key": "2022060923194762800_BIB29",
      "unstructured": "Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res\u20082001;61:1354-7."
    },
    {
      "key": "2022060923194762800_BIB30",
      "doi-asserted-by": "crossref",
      "unstructured": "Qiao Y, Spitz MR, Guo Z, et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res\u20082002;509:165-74.",
      "DOI": "10.1016/S0027-5107(02)00219-1"
    },
    {
      "key": "2022060923194762800_BIB31",
      "doi-asserted-by": "crossref",
      "unstructured": "Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis\u20082002;23:295-9.",
      "DOI": "10.1093/carcin/23.2.295"
    },
    {
      "key": "2022060923194762800_BIB32",
      "unstructured": "Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers & Prev\u20081999;8:525-32."
    },
    {
      "key": "2022060923194762800_BIB33",
      "doi-asserted-by": "crossref",
      "unstructured": "Klintschar M, Neuhuber F. Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci\u20082000;45:669-73.",
      "DOI": "10.1520/JFS14745J"
    },
    {
      "key": "2022060923194762800_BIB34",
      "doi-asserted-by": "crossref",
      "unstructured": "Therneau T, Granbsch P. Modeling survival data: extending the Cox model. New York: Springer-Verlag; 2000.",
      "DOI": "10.1007/978-1-4757-3294-8"
    },
    {
      "key": "2022060923194762800_BIB35",
      "doi-asserted-by": "crossref",
      "unstructured": "Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer\u20082001;92:562-7.",
      "DOI": "10.1002/ijc.1228"
    },
    {
      "key": "2022060923194762800_BIB36",
      "doi-asserted-by": "crossref",
      "unstructured": "Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis\u20082002;23:599-603.",
      "DOI": "10.1093/carcin/23.4.599"
    },
    {
      "key": "2022060923194762800_BIB37",
      "doi-asserted-by": "crossref",
      "unstructured": "Palli D, Russo A, Masala G, et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer\u20082001;94:121-7.",
      "DOI": "10.1002/ijc.1433"
    },
    {
      "key": "2022060923194762800_BIB38",
      "unstructured": "Zhou W, Liu G, Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res\u20082002;62:1377-81."
    },
    {
      "key": "2022060923194762800_BIB39",
      "doi-asserted-by": "crossref",
      "unstructured": "Sturgis EM, Zheng R, Li L, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis\u20082000;21:2219-23.",
      "DOI": "10.1093/carcin/21.12.2219"
    },
    {
      "key": "2022060923194762800_BIB40",
      "doi-asserted-by": "crossref",
      "unstructured": "Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis\u20082002;23:1321-5.",
      "DOI": "10.1093/carcin/23.8.1321"
    },
    {
      "key": "2022060923194762800_BIB41",
      "doi-asserted-by": "crossref",
      "unstructured": "Tang D, Cho S, Rundle A, et al. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat\u20082002;75:159-66.",
      "DOI": "10.1023/A:1019693504183"
    },
    {
      "key": "2022060923194762800_BIB42",
      "doi-asserted-by": "crossref",
      "unstructured": "Shen H, Spitz MR, Qiao Y, et al. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer\u20082003;107:84-8.",
      "DOI": "10.1002/ijc.11346"
    }
  ],
  "container-title": "Cancer Epidemiology, Biomarkers &amp; Prevention",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://aacrjournals.org/cebp/article-pdf/13/8/1271/2263080/1271-1275.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "https://aacrjournals.org/cebp/article-pdf/13/8/1271/2263080/1271-1275.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2022,
        6,
        10
      ]
    ],
    "date-time": "2022-06-10T04:21:07Z",
    "timestamp": 1654834867000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://aacrjournals.org/cebp/article/13/8/1271/116083/XPD-Polymorphism-and-Risk-of-Subsequent-Cancer-in"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        8,
        1
      ]
    ]
  },
  "references-count": 42,
  "journal-issue": {
    "issue": "8",
    "published-online": {
      "date-parts": [
        [
          2004,
          8,
          6
        ]
      ]
    },
    "published-print": {
      "date-parts": [
        [
          2004,
          8,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1158/1055-9965.1271.13.8",
  "relation": {},
  "ISSN": [
    "1055-9965",
    "1538-7755"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2004,
        8,
        1
      ]
    ]
  }
}